Abstract
Three doses of the commercially available hepatitis B vaccine were administered to each of 43 anti-hepatitis B surface antigen antibody-negative children (including 32 hemophiliacs) who were regularly receiving blood product transfusions. Forty-two (98%) of them had demonstrable anti-hepatitis B surface antigen antibody in their serum, indicating that this group of patients responds favorably to the vaccine.
Original language | English (US) |
---|---|
Pages (from-to) | 68-70 |
Number of pages | 3 |
Journal | Pediatric infectious disease |
Volume | 5 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 1986 |
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Microbiology (medical)